Kainos Medicine, Inc., based in South Korea, is a clinical-stage company that specializes in the research and development of innovative medicines for brain diseases, cancers and infectious diseases, led by researchers who have years of experience and success in new drug discovery and development, and an executive team that has experience with NASDAQ-listed companies. Kainos receives specialized counsel on product selection, evaluation and external licensing deals from advisory boards and business development consultants who have skills and significant experience in global drug development.
View Top Employees from Kainos MedicineWebsite | http://www.kainosmedicine.com |
Revenue | $6 million |
Employees | 2 (2 on RocketReach) |
Founded | 2007 |
Address | 4F Institute Pasteur Korea 16 712beon-gil Bundang-gu, Seongnam-si, Gyeonggi-do, KR |
Phone | (822) 567-7419 |
Fax | (822) 552-1470 |
Industry | Manufacturing General, Health Care, Drug Discovery, Manufacturing, Biotechnology |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Kainos Medicine employee's phone or email?
The Kainos Medicine annual revenue was $6 million in 2024.
Jae Lee is the President of Kainos Medicine.
2 people are employed at Kainos Medicine.
Kainos Medicine is based in Seongnam-si, Gyeonggi-do.
The NAICS codes for Kainos Medicine are [325, 3254, 32, 32541].
The SIC codes for Kainos Medicine are [283, 28].